DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

183 hedge funds and large institutions have $1.61B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 55 increasing their positions, 67 reducing their positions, and 22 closing their positions.

Holders
183
Holders Change
+10
Holders Change %
+5.78%
% of All Funds
3.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
34
Increased
55
Reduced
67
Closed
22
Calls
$5.27M
Puts
$8.48M
Net Calls
-$3.21M
Net Calls Change
+$70K

Top Buyers

1
MC
1
Maverick Capital
Texas
$34.6M
2
PCH
2
Polar Capital Holdings
United Kingdom
$27.7M
3
Morgan Stanley
3
Morgan Stanley
New York
$21.9M
4
AG
4
Artal Group
Luxembourg
$20.5M
5
BM
5
Bridger Management
New York
$15.1M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$15.5M
2
Citadel Advisors
2
Citadel Advisors
Florida
$12.5M
3
UBS Group
3
UBS Group
Switzerland
$35.3M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$3.78M
5
CCM
5
Camber Capital Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
QT
201
Quantbot Technologies
New York
– -$27K -1,256 Closed
PWPS
202
Pinnacle Wealth Planning Services
Ohio
– -$5K -227 Closed
ICP
203
Interchange Capital Partners
Pennsylvania
– -$1K -69 Closed
5 6 7 8
9